Tissue factor and tissue factor pathway inhibitor levels in trophoblast cells: implications for placental hemostasis
Anat Aharon1, Benjamin Brenner1,Tamar Katz1,Yohei Miyagi2, Naomi Lanir1
1Department of Hematology and Bone marrow Transplantation , Rambam Medical Center and the Bruce Rappaport Faculty of Medicine,Technion, Haifa Israel 2Laboratory for Molecular Diagnostics and Pathology, Kanagawa Cancer Center Research Institute,Yokohama,
Summary
The placenta is a highly vascularized organ with fetal and maternalblood supply. Syncytiotrophoblasts (STB),which line the placentavillous are possibly involved in local hemostatic mechanisms.The aim of this study was to evaluate the levels of tissuefactor (TF) and its inhibitors, tissue factor pathway inhibitor(TFPI,TFPI-2), in STB model within hemostatic and inflammatoryenvironments. Human primary STB cell cultures were characterizedby vascular and hormonal markers. TF and TFPImRNA expression, protein levels and activity were determinedand compared to human umbilical vein endothelial cells (HUVEC). High levels of TF were demonstrated in STB cellscompared to low levels in HUVEC. In contrast, STB expressedlower TFPI levels than HUVEC. LPS and TNFa increased thehigh constitutive TF in STB, whereas LPS and IL-1a furtherreduced TFPI levels. The procoagulant tendency of STB identifiedby us may reflect the physiological need for immediateinhibition of hemorrhage in the placental inter-villous spaces inbasal and inflammatory conditions.This hemostatic balance maybe critical for normal placental function and pregnancy outcome. DOI
http://dx.doi.org/10.1160/TH04-01-0033